Alzheimer's disease

A safer Alzheimer's drug than Biogen's aducanumab? Denali-WashU drug shows better profile in mice
Fierce Biotech
Thu, 02/18/21 - 11:04 am
Alzheimer's disease
Denali Therapeutics
Biogen
aducanumab
HAE-4
Pfizer, Verily-backed Alzheimer's biotech Cortexyme hit by FDA partial hold over liver toxicity
Fierce Biotech
Tue, 02/16/21 - 11:10 am
Cortexyme
FDA
Pfizer
Verily
Alzheimer's disease
COR388
AC Immune has 'remarkable' Alzheimer's vaccine data. Just don't ask to see them
Endpoints
Thu, 02/11/21 - 10:53 am
AC Immune
Alzheimer's disease
vaccines
clinical trials
Roche refreshingly cautious on Alzheimer's hopeful gantenerumab amid growing hype from rivals
Fierce Biotech
Fri, 02/5/21 - 10:52 am
Roche
gantenerumab
Alzheimer's disease
Biogen laser-focused on Alzheimer's drug as rest of business falters
BioPharma Dive
Wed, 02/3/21 - 10:55 pm
Biogen
earnings
aducanumab
Alzheimer's disease
FDA extends review period for Biogen's Alzheimer's drug
Reuters
Fri, 01/29/21 - 10:06 am
Biogen
Eisai
FDA
aducanumab
Alzheimer's disease
Biohaven Provides Update On Phase 2/3 Trial And Alzheimer's Disease Program
BioSpace
Mon, 01/18/21 - 01:13 pm
Biohaven
Alzheimer's disease
clinical trials
troriluzole
Here's the Top FDA Decision to Watch in 2021
Motley Fool
Sun, 01/17/21 - 04:56 pm
FDA
Biogen
aducanumab
Alzheimer's disease
Could Lilly’s donanemab readout in Alzheimer’s boost Biogen’s prospects?
Pharmaforum
Thu, 01/14/21 - 10:52 am
Eli Lilly
Alzheimer's disease
clinical trials
donanemab
Lilly rockets up on mixed Alzheimer's results
BioPharma Dive
Mon, 01/11/21 - 06:53 pm
Eli Lilly
Alzheimer's disease
clinical trials
donanemab
3 FDA Dates Biotech Investors Should Circle in 2021
Motley Fool
Sat, 12/26/20 - 08:27 pm
FDA
biotech
Bluebird Bio
ide-cel
Multiple Myeloma
Biogen
aducanumab
Alzheimer's disease
targeted therapeutics
umbralisib
maringal zone lymphoma
Novo takes the plunge in Alzheimer’s
EP Vantage
Thu, 12/17/20 - 06:20 pm
Novo Nordisk
Rybelsus
Alzheimer's disease
Second Shot at Alzheimer's Proves Unsuccessful for vTv Therapeutics' Azeliragon
BioSpace
Wed, 12/16/20 - 11:27 am
vTv Therapeutics
azeliragon
Alzheimer's disease
Public Citizen Demands Investigation into "Inappropriate Collaboration" Between FDA and Biogen Over Alzheimer's Drug
BioSpace
Wed, 12/9/20 - 10:59 pm
Biogen
OIG
HHS
aducanumab
Public Citizen
Alzheimer's disease
Research Alzheimer's discovery generates novel drug candidate for early intervention
Fierce Biotech
Sat, 12/5/20 - 11:31 pm
Alzheimer's disease
Case Western Reserve
Eli Lilly Designs P-Tau Biomarker Assay for Early Alzheimer’s Disease Diagnosis
BioSpace
Wed, 11/11/20 - 11:09 pm
Eli Lilly
Alzheimer's disease
biomarker assays
biomarkers
diagnostics
P-tau
Biogen ‘continues to work’ with FDA on Alzheimer's drug candidate despite regulatory setback
Biopharma Reporter
Tue, 11/10/20 - 10:36 am
Biogen
FDA
Alzheimer's disease
aducanumab
5 takeaways from the FDA's high-stakes meeting for Biogen's Alzheimer's drug
BioPharma Dive
Mon, 11/9/20 - 08:56 pm
Biogen
FDA
Alzheimer's disease
aducanumab
clinical trials
amyloid
Why Biogen Stock Is Tanking Today
Motley Fool
Mon, 11/9/20 - 11:02 am
Biogen
aducanumab
FDA
Alzheimer's disease
FDA advisers vote against Biogen's Alzheimer's drug, leaving its future in doubt
Biopharma Dive
Fri, 11/6/20 - 08:46 pm
Biogen
aducanumab
FDA
advisory panels
Alzheimer's disease

Pages